Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 10:15:948827.
doi: 10.3389/fnmol.2022.948827. eCollection 2022.

Editorial: Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders

Affiliations
Editorial

Editorial: Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders

Fabio Coppedè et al. Front Mol Neurosci. .
No abstract available

Keywords: DNA methylation; amyotrophic lateral sclerosis; autism; epigenetics; miRNA; neurodegenerative diseases; neurodevelopmental disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders

References

    1. Aref-Eshghi E., Kerkhof J., Pedro V. P., France G. D., Barat-Houari M., Ruiz-Pallares N., et al. . (2021). Evaluation of DNA methylation episignatures for diagnosis and phenotype correlations in 42 mendelian neurodevelopmental disorders. Am. J. Hum. Genet. 108, 1161–1163. 10.1016/j.ajhg.2020.01.019 - DOI - PMC - PubMed
    1. Bellver-Sanchis A., Pallàs M., Griñán-Ferré C. (2021). The contribution of epigenetic inheritance processes on age-related cognitive decline and Alzheimer's disease. Epigenomes 5, 15. 10.3390/epigenomes5020015 - DOI - PMC - PubMed
    1. Coppedè F. (2020). Epigenetics of neuromuscular disorders. Epigenomics 12, 2125–2139. 10.2217/epi-2020-0282 - DOI - PubMed
    1. Coppedè F. (2021). The diagnostic potential of the epigenome in autism spectrum disorders. Epigenomics 13, 1587–1590. 10.2217/epi-2021-0338 - DOI - PubMed
    1. Coppedè F. (2022). Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective. Neural Regen. Res. 17, 1745–1747. 10.4103/1673-5374.332145 - DOI - PMC - PubMed

Publication types

LinkOut - more resources